688289.SS
Price:
$19.99
Market Cap:
$11.38B
Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract diseases, STDs, digestive tract diseases, prenatal and postnatal care, and genetic diseases, as well as instruments and other consumables. It serves hospitals and laboratories. The company was founded in 2008 and is based in Changsha, China.
Industry
Medical - Instruments & Supplies
IPO Date
2020-08-28
Stock Exchange
SHH
Ticker
688289.SS
According to Sansure Biotech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 40.80. This represents a change of -9.15% compared to the average of 44.91 of the last 4 quarters.
The mean historical PE Ratio of Sansure Biotech Inc. over the last ten years is 351.27. The current 40.80 PE Ratio has changed 1.06% with respect to the historical average. Over the past ten years (40 quarters), 688289.SS's PE Ratio was at its highest in in the September 2019 quarter at 965.76. The PE Ratio was at its lowest in in the March 2019 quarter at -18941.94.
Average
351.27
Median
24.21
Minimum
-2641.87
Maximum
4.16K
Discovering the peaks and valleys of Sansure Biotech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 372.68%
Maximum Annual PE Ratio = 4.16K
Minimum Annual Increase = -257.54%
Minimum Annual PE Ratio = -2641.87
Year | PE Ratio | Change |
---|---|---|
2024 | 48.49 | 56.42% |
2023 | 31.00 | 372.68% |
2022 | 6.56 | -37.63% |
2021 | 10.52 | -39.63% |
2020 | 17.42 | -98.52% |
2019 | 1.18K | -71.75% |
2018 | 4.16K | -257.54% |
The current PE Ratio of Sansure Biotech Inc. (688289.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
28.68
5-year avg
22.80
10-year avg
351.27
Sansure Biotech Inc.’s PE Ratio is greater than Zhejiang Orient Gene Biotech Co., Ltd. (-8.36), greater than Intco Medical Technology Co., Ltd. (9.31), greater than Beijing Roborock Technology Co., Ltd. (23.93), greater than Winner Medical Co., Ltd. (37.26), greater than Shanghai MicroPort Endovascular MedTech Co., Ltd. (24.05),
Company | PE Ratio | Market cap |
---|---|---|
-8.36 | $4.60B | |
9.31 | $14.72B | |
23.93 | $44.47B | |
37.26 | $28.58B | |
24.05 | $10.57B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sansure Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sansure Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sansure Biotech Inc.'s PE Ratio?
How is the PE Ratio calculated for Sansure Biotech Inc. (688289.SS)?
What is the highest PE Ratio for Sansure Biotech Inc. (688289.SS)?
What is the 3-year average PE Ratio for Sansure Biotech Inc. (688289.SS)?
What is the 5-year average PE Ratio for Sansure Biotech Inc. (688289.SS)?
How does the current PE Ratio for Sansure Biotech Inc. (688289.SS) compare to its historical average?